NEW YORK, Sept. 30, 2024 /PRNewswire/ — Moore Law, PLLC, a shareholder litigation law firm located on Wall Street, is investigating potential claims against: Akero Therapeutics, Inc. (“Akero”) (NASDAQ:AKRO) Shareholders should email Fletcher@fmoorelaw.com; please contact only if shares…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.